Cargando…

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol

Several therapeutic options are currently available to treat excessive daytime sleepiness (EDS) in patients suffering from narcolepsy or obstructive sleep apnea. However, there are no comparisons between the various wake‐promoting agents in terms of mechanism of action, efficacy, or safety. The goal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krief, Stéphane, Berrebi‐Bertrand, Isabelle, Nagmar, Isabelle, Giret, Martin, Belliard, Simon, Perrin, David, Uguen, Marilyne, Robert, Philippe, Lecomte, Jeanne‐Marie, Schwartz, Jean‐Charles, Finance, Olivier, Ligneau, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381683/ https://www.ncbi.nlm.nih.gov/pubmed/34423920 http://dx.doi.org/10.1002/prp2.855

Ejemplares similares

Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro‐arrhythmia Assay initiative studies
por: Ligneau, Xavier, et al.
Publicado: (2017)

Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approach
por: Lehert, Philippe, et al.
Publicado: (2020)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity
por: Kalivas, Peter W.
Publicado: (2007)

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
por: Hersey, Melinda, et al.
Publicado: (2021)

Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration
por: Wagener, Nele, et al.
Publicado: (2022)

Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Lökk, Johan
Publicado: (2010)

Waking up to modafinil in shift work sleep disorder
por: Gude, Dilip
Publicado: (2011)

Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation
por: Schmitz, Joy M., et al.
Publicado: (2012)

Practical Use and Risk of Modafinil, a Novel Waking Drug
por: Kim, Dongsoo
Publicado: (2012)

Differential effects of wake promoting drug modafinil in aversive learning paradigms
por: Shanmugasundaram, Bharanidharan, et al.
Publicado: (2015)

Genetic lesioning of histamine neurons increases sleep–wake fragmentation and reveals their contribution to modafinil-induced wakefulness
por: Yu, Xiao, et al.
Publicado: (2019)

P148 Solriamfetol Titration & AdministRaTion (START): Dosing and titration strategies in patients with narcolepsy starting solriamfetol
por: Thorpy, M, et al.
Publicado: (2021)

Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
por: Bhatt, Meha, et al.
Publicado: (2016)

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression
por: Meng, Qing, et al.
Publicado: (2018)

Solriamfetol for the Use of Narcolepsy: A Systematic Review
por: Iturburu, Alisson, et al.
Publicado: (2022)

Corrigendum: Genetic lesioning of histamine neurons increases sleep–wake fragmentation and reveals their contribution to modafinil-induced wakefulness
por: Yu, Xiao, et al.
Publicado: (2019)

Update on the treatment of narcolepsy: clinical efficacy of pitolisant
por: Calik, Michael W
Publicado: (2017)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial
por: Dauvilliers, Yves, et al.
Publicado: (2020)

Disharmony between wake- and respiration-promoting activities: effects of modafinil on ventilatory control in rodents
por: Terada, Jiro, et al.
Publicado: (2016)

Quantification of the calcium signaling deficit in muscles devoid of triadin
por: Manno, Carlo, et al.
Publicado: (2022)

P147 Solriamfetol Titration & AdministRaTion (START): Characteristics of patients with obstructive sleep apnoea (OSA) and prescriber rationale for starting treatment with solriamfetol
por: Singh, H, et al.
Publicado: (2021)

Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)

The Role of Nucleus Accumbens Core/Shell in Sleep-Wake Regulation and their Involvement in Modafinil-Induced Arousal
por: Qiu, Mei-Hong, et al.
Publicado: (2012)

Estudio WAKE de vida real en pacientes con narcolepsia con cataplejía tratados con pitolisant no respondedores a tratamientos previos
por: del Río-Villegas, Rafael, et al.
Publicado: (2022)

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
por: Romigi, Andrea, et al.
Publicado: (2018)

Treat the Symptom, Not the Cause? Pitolisant for Sleepiness in Obstructive Sleep Apnea
por: Trotti, Lynn Marie
Publicado: (2020)

Solriamfetol impurities: Synthesis, characterization, and analytical method (UPLC-UV) validation
por: Al-Rifai, Nafisah, et al.
Publicado: (2023)

Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report
por: Pellitteri, Gaia, et al.
Publicado: (2020)

Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Wake up and smell the dopamine: new mechanisms mediating dopamine activity fluctuations related to sleep and psychostimulant sensitivity
por: Kesner, Andrew J., et al.
Publicado: (2020)

The wake-promoting drug modafinil stimulates specific hypothalamic circuits to promote adaptive stress responses in an animal model of PTSD
por: Cohen, S, et al.
Publicado: (2016)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Modafinil in the treatment of excessive sleepiness
por: Schwartz, Jonathan RL
Publicado: (2009)

Fixed drug eruptions with modafinil
por: Ghoshal, Loknath, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_osk396r3as4teursp3fv18vvjq